Fludarabine in Waldenstrom's macroglobulinemia.


Waldenstrom's macroglobulinemia (WM), a rare B-cell malignancy, is incurable. Conventional treatment consists of alkylating agents (especially chlorambucil), with or without corticosteroids. Purine analogues such as fludarabine are also active. Response rates to first-line therapy range from 38% to 85%. Discrepancies in response rates between different… (More)
DOI: 10.1586/ehm.13.17


3 Figures and Tables